M. Rendon

发表

Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.

Susan C. Taylor, J. Ortonne, L. Hynan, 2011, Journal of the American Academy of Dermatology.

Lidocaine/tetracaine peel in topical anesthesia prior to laser-assisted hair removal: Phase-II and Phase-III study results

T. Alster, R. Fitzpatrick, M. Rendon, 2014, The Journal of dermatological treatment.

SCULPTRA INJECTIONS New Age Medical Clinic 90 Millburn Ave . , Suite 201 Millburn NJ 07041 ( 973 ) 313 -‐ 0028 Dr Maria Romanenko , DO Board Certified : Family Medicine & Aesthetics FREE CONSULTATION

M. Rendon, 2012 .

Long‐term aesthetic outcomes with injectable poly‐l‐lactic acid: observations and practical recommendations based on clinical experience over 5 years

M. Rendon, 2012, Journal of cosmetic dermatology.

Natural approaches to management of photoaging.

D. Rigel, M. Rendon, C. Ditre, 2008, Seminars in cutaneous medicine and surgery.

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials

John D. Davis, J. Silverberg, Meng Li, 2019, Journal of drugs in dermatology : JDD.

The use of fillers and botulinum toxin type A in combination with superficial glycolic acid (alpha-hydroxy acid) peels: optimizing injection therapy with the skin-smoothing properties of peels.

M. Rendon, Brenda L. Edison, Cheryl Effron, 2007, Cutis.

Increasing our understanding of pigmentary disorders.

Susan C. Taylor, J. Nordlund, P. Grimes, 2006, Journal of the American Academy of Dermatology.

Review of skin-lightening agents.

M. Rendon, J. Gaviria, 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Chromoblastomycosis in a patient with chronic obstructive pulmonary disease

M. Rendon, G. Okan, 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

Successful treatment of aggressive pyoderma gangrenosum with pulse steroids and chlorambucil.

F. Kerdel, M. Rendon, B. Resnik, 1992, Journal of the American Academy of Dermatology.

Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience.

Susan C. Taylor, M. Rendon, A. Alexis, 2019, Journal of the American Academy of Dermatology.

Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature.

M. Rendon, John Keeling, L. Cardona, 2008, Cutis.

Treatment of melasma.

M. Picardo, M. Berneburg, M. Rendon, 2006, Journal of the American Academy of Dermatology.

A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma

H. Lui, M. Picardo, W. Westerhof, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing.

M. Rendon, Joel L Cohen, I. Starker, 2010, The Journal of clinical and aesthetic dermatology.

Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials

A. Grada, N. Sadick, M. Gold, 2020 .

Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.

N. Sadick, M. Gold, S. Tyring, 2018, Journal of drugs in dermatology : JDD.

Ethnic considerations in the treatment of Hispanic and Latin‐American patients with hyperpigmentation

M. Rendon, D. Hexsel, I. Arellano, 2006, The British journal of dermatology.

Topical treatment of hyperpigmentation disorders.

M. Rendon, S. Horwitz, 2012, Annales de dermatologie et de venereologie.

Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.

M. Rendon, Luz E. Colón, Lori A. Johnson, 2008, Cutis (New York, N.Y.).

TherapeuTics for The clinician Mequinol 2 % / Tretinoin 0 . 01 % Topical Solution for the Treatment of Melasma in Men : A Case Series and Review of the Literature

M. Rendon, John Keeling, L. Cardona, 2008 .

Triple Combination Cream and Glycolic Acid Peels for the Treatment of Moderate to Severe Melasma

M. Rendon, Luz E. Colón, Lori A. Johnson, 2009 .

Cosmeceutical Skin Lighteners

M. Rendon, Y. Vazquez, Suzanne Micciantuono, 2013 .

Utilizing combination therapy to optimize melasma outcomes.

M. Rendon, 2004, Journal of drugs in dermatology : JDD.

Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.

M. Rendon, Sylvia Barkovic, 2016, Journal of drugs in dermatology : JDD.

Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.

M. Rendon, L. Dryer, 2016, Journal of drugs in dermatology : JDD.

Special Considerations in Darker Skin

M. Rendon, C. L. Anthony, 2017 .

Open-label treatment of moderate or marked melasma with a 4% hydroquinone skin care system plus 0.05% tretinoin cream.

M. Gold, M. Rendon, S. Bruce, 2013, The Journal of clinical and aesthetic dermatology.

Top-Accessed Article: Glycolic Acid Peels in the Treatment of Melasma

M. Rendon, 2010 .

Clinical role and application of superficial chemical peels in today's practice.

M. Rendon, Joel L Cohen, I. Starker, 2009, Journal of drugs in dermatology : JDD.

Hyperpigmentation Disorders in Hispanic Population in the United States

M. Rendon, 2019, Journal of drugs in dermatology : JDD.

Delayed wound healing after laser resurfacing.

M. Rendon, J. Trent, G. Okan, 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.

Rod J. Rohrich, G. Monheit, L. Baumann, 2011, Aesthetic surgery journal.

A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles.

Rod J. Rohrich, G. Monheit, L. Baumann, 2010, Journal of the American Academy of Dermatology.

Subject Global Evaluation and Subject Satisfaction Using Injectable Poly-l-Lactic Acid versus Human Collagen for the Correction of Nasolabial Fold Wrinkles

Rod J. Rohrich, G. Monheit, L. Baumann, 2011, Plastic and reconstructive surgery.

Treatment of the aged hand with injectable poly-l-lactic acid

M. pinzon-plazas, M. Rendon, L. Cardona, 2010, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.

J. Weiss, M. Rendon, E. Tanghetti, 2018, Journal of drugs in dermatology : JDD.

Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.

M. Rendon, G. Webster, M. Bradshaw, 2007, Journal of the American Academy of Dermatology.

The effects of a high glycerin content hydrogel premolded mask dressing on post-laser resurfacing wounds

M. Rendon, G. Okan, 2011, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Acne treatment patterns, expectations, and satisfaction among adult females of different races/ethnicities

A. Degboe, T. Wilcox, M. Rendon, 2015, Clinical, cosmetic and investigational dermatology.

The Mechanism of Action of Topical Retinoids for the Treatment of Nonmalignant Photodamage , Part 1

M. Rendon, P. Farris, 2010 .

Erythema Dyschromicum Perstans : Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study

M. pinzon-plazas, M. Rendon, L. Cardona, 2010 .

Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin.

P. Cruz, M. Rendon, P. Bergstresser, 1989, Journal of the American Academy of Dermatology.